Abstract
The availability of electronic medical records (EMR) data has grown dramatically in recent years, and clustering methods are often applied to them for a variety of purposes, including finding unknown subtypes of diseases. The abundance and redundancy of information in EMR data raises the need to identify and rank the features that are most relevant for clustering.
Here we propose FRIGATE, an ensemble feature ranking algorithm for clustering, which uses the concepts of Shapley value and Multiplicative Weights. FRIGATE derives the importance of features from multiple clustering solutions on sub-groups of features. For each clustering solution a small group of features is ranked in a Shapley-like framework, and multiplicative weights are applied to limit the randomness of their choice. FRIGATE outperforms previously suggested ensemble ranking algorithms, both in solution quality and in speed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported in part by a grant from the Tel Aviv University Center for AI and Data Science (TAD). ES was supported in part by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel-Aviv University.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Addresses: 1 Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
Data Availability
All real data used in this paper are from publicly available sources. See Table 2 for details.
